BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 9477772)

  • 1. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.
    Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
    Photochem Photobiol; 1998 Jan; 67(1):140-9. PubMed ID: 9477772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin.
    Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
    Photochem Photobiol; 1999 Jan; 69(1):61-70. PubMed ID: 10063801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
    Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
    Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo measurement of 5-aminolaevulinic acid-induced protoporphyrin IX photobleaching: a comparison of red and blue light of various intensities.
    Nadeau V; O'Dwyer M; Hamdan K; Tait I; Padgett M
    Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):170-4. PubMed ID: 15238094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes.
    Pudroma X; Juzeniene A; Ma LW; Iani V; Moan J
    J Environ Pathol Toxicol Oncol; 2011; 30(3):235-40. PubMed ID: 22126616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
    Liu B; Farrell TJ; Patterson MS
    Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester.
    Juzenas P; Sharfaei S; Moan J; Bissonnette R
    J Photochem Photobiol B; 2002 May; 67(1):11-7. PubMed ID: 12007462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.
    Boere IA; Robinson DJ; de Bruijn HS; Kluin J; Tilanus HW; Sterenborg HJ; de Bruin RW
    Photochem Photobiol; 2006; 82(6):1638-44. PubMed ID: 16879035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy.
    Kruijt B; de Bruijn HS; van der Ploeg-van den Heuvel A; de Bruin RW; Sterenborg HJ; Amelink A; Robinson DJ
    Photochem Photobiol; 2008; 84(6):1515-27. PubMed ID: 18557821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
    van der Veen N; Hebeda KM; de Bruijn HS; Star WM
    Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
    Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
    Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated illumination at low fluence rate photodynamic therapy in mice.
    Middelburg TA; Van Zaane F; De Bruijn HS; Van Der Ploeg-van den Heuvel A; Sterenborg HJ; Neumann HA; De Haas ER; Robinson DJ
    Photochem Photobiol; 2010; 86(5):1140-6. PubMed ID: 20553407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo.
    Finlay JC; Conover DL; Hull EL; Foster TH
    Photochem Photobiol; 2001 Jan; 73(1):54-63. PubMed ID: 11202366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid.
    Bissonnette R; Sharfaei S; Viau G; Liu Y
    Br J Dermatol; 2004 Sep; 151(3):653-5. PubMed ID: 15377353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination.
    Thissen MR; de Blois MW; Robinson DJ; de Bruijn HS; Dutrieux RP; Star WM; Neumann HA
    J Invest Dermatol; 2002 Feb; 118(2):239-45. PubMed ID: 11841539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.
    Cottrell WJ; Paquette AD; Keymel KR; Foster TH; Oseroff AR
    Clin Cancer Res; 2008 Jul; 14(14):4475-83. PubMed ID: 18628462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin.
    Van der Veen N; De Bruijn HS; Star WM
    Int J Cancer; 1997 Jul; 72(1):110-8. PubMed ID: 9212231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
    Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
    Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy.
    Boere IA; Robinson DJ; de Bruijn HS; van den Boogert J; Tilanus HW; Sterenborg HJ; de Bruin RW
    Photochem Photobiol; 2003 Sep; 78(3):271-7. PubMed ID: 14556314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.